reference/6115328

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6115328

Outgoing Links

Predicate	Object
contentType	Journal Article
issn	2374-4677
issueIdentifier	1
pageRange	135-
publicationName	npj Breast Cancer
startingPage	135
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_55bca5273841465b8655f16e7608e302 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_7ebe8451f5ecc36d2e7e50b990e08ce0
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d592f754c7e70ba5f9a612aa8b6a9e20 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f44e02fcf9fa27484f2fa88838529c69
bibliographicCitation	Setton J, Selenica P, Mukherjee S, Shah R, Pecorari I, McMillan B, Pei IX, Kemel Y, Ceyhan-Birsoy O, Sheehan M, Tkachuk K, Brown DN, Zhang L, Cadoo K, Powell S, Weigelt B, Robson M, Riaz N, Offit K, Reis-Filho JS, Mandelker D. Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombination. NPJ Breast Cancer. 2021 Oct 11;7(1):135. PMID: 34635660; PMCID: PMC8505423.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4154-0567 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8183-4765 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e27eb1118da2725c83469038b94371e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8591e21ce120845f06fc2beaca5b1d65 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb2e2994e4132a07eb081ef843de1dbb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2df805e373e76216c24f0e3843df3ee0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2969-3173 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9927-1270 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2bb3f6d781a24540c409c6bf05f2acb6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9873-5862 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1474-2553 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3109-1692 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4a72dc20c01cb548f76ca2d698142c65 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1431356f47c31cb67b77a75c00890775 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2f894b47d560bca97751781f7c8353d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5a9e5074aa22de50018db68dcea689c1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fd01b6a1f40c81eb824f5b3e4b739465 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c72d6c103272f59738cdd11d60bde013 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5042-5651 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3639-7113 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9961-6152 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_47915a06950b63bae541a73c94acf639
date	2021-10-11^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC8505423 https://doi.org/10.1038/s41523-021-00339-0 https://pubmed.ncbi.nlm.nih.gov/34635660
isPartOf	https://portal.issn.org/resource/ISSN/2374-4677 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/44777
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombination
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11451 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_27af779b9d208b1aa16de86de813e241 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c093401b54d0d705d1bc7b045a24c672 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8937 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10883 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_364dcd35384393b0b80bb65acf6ef472 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8752 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9091f9d0b2e1bc76ac280a84a8e3f42d

Showing number of triples: 1 to 55 of 55.